Eldar M, Griffin J C, Abbott J A, Benditt D, Bhandari A, Herre J M, Benson D W, Scheinman M M
J Am Coll Cardiol. 1987 Sep;10(3):600-7. doi: 10.1016/s0735-1097(87)80203-6.
A permanent pacemaker was inserted in eight patients with the long QT syndrome. All had recurrent syncope or seizures, six had documented torsade de pointes and four had aborted sudden death. Among the eight patients, permanent pacing was instituted in three who were unsuccessfully treated with both a beta-adrenergic blocking agent and left cardiothoracic sympathectomy, and in two who proved refractory or intolerant to beta-blockers. Another three patients had pacemaker implantation and long-term beta-blocker therapy because of spontaneous atrioventricular (AV) block in one, aborted sudden death in one and patient preference in one. After pacing (70 to 85 beats/min), there was no significant change in the mean corrected QT interval, but the mean QT interval decreased significantly (534.4 +/- 51.4 to 425.6 +/- 18.9 ms, p less than 0.0001). Over a mean follow-up period of 35.1 +/- 18.9 months, all patients are alive and currently free of syncope. One patient without a history of stress-induced syncope had two syncopal episodes (believed to be due to hyperventilation) while under severe emotional stress, but has been symptom free for the past 5 years. One patient with an atrial demand (AAI) pacemaker developed dizziness due to documented episodes of AV block, but remains asymptomatic after conversion to atrial rate-responsive dual chamber (DDD) pacing. Either atrial or ventricular pacing combined with beta-blocker therapy appears to be effective treatment for a subset of patients with the long QT syndrome, by either preventing episodes of torsade de pointes or alleviating symptoms due to bradycardia from beta-blocker therapy.
8例长QT综合征患者植入了永久性起搏器。所有患者均有反复晕厥或癫痫发作,6例记录到尖端扭转型室速,4例有心脏骤停。8例患者中,3例接受β肾上腺素能阻滞剂和左胸交感神经切除术治疗无效,2例对β受体阻滞剂难治或不耐受,均植入了永久性起搏器。另外3例患者植入起搏器并长期接受β受体阻滞剂治疗,原因分别是1例出现自发性房室传导阻滞,1例有心脏骤停,1例出于患者自身意愿。起搏后(心率70至85次/分钟),平均校正QT间期无显著变化,但平均QT间期显著缩短(从534.4±51.4毫秒降至425.6±18.9毫秒,p<0.0001)。平均随访35.1±18.9个月,所有患者均存活,目前无晕厥发作。1例无应激性晕厥病史的患者在严重情绪应激时出现2次晕厥发作(认为是由于过度换气),但在过去5年中一直无症状。1例心房按需(AAI)起搏器患者因记录到的房室传导阻滞发作而出现头晕,但转换为心房频率应答双腔(DDD)起搏后仍无症状。心房或心室起搏联合β受体阻滞剂治疗似乎对一部分长QT综合征患者有效,可预防尖端扭转型室速发作或减轻β受体阻滞剂治疗所致心动过缓的症状。